FDA Should Nix Drug Risk Proposal, Advocacy Group Says
Consumer advocacy group Public Citizen argued Wednesday that the U.S. Food and Drug Administration should revoke a proposal that the group said would allow pharmaceutical companies to downplay the risks of...To view the full article, register now.
Already a subscriber? Click here to view full article